Full name
BIOMEDYCYNA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.90.E - Healthcare
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
68.20.Z - Rental and management of own or leased real estate
86.21.Z - General medical practice
86.22.Z - Specialist medical practice
86.90.A - Healthcare
86.90.D - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Assets | 496 | 528,7 | 572,2 | 8,2 |
Gross profit (loss) | 43,7 | -9,4 | 62,8 | 765,6 |
EBITDA | 56,3 | 0,6 | 80,7 | 12 727,3 |
Net profit (loss) | 39,8 | -9,9 | 57,4 | 679,9 |
Cash | 187,2 | 113,7 | 58,8 | -48,3 |
Liabilities and provisions for liabilities | 146,4 | 188,9 | 175,1 | -7,3 |
Net income from sale | 94,1 | 81 | 123 | 51,9 |
Short time liabilities | 145,6 | 188,9 | 175,1 | -7,3 |
Equity capital | 349,6 | 339,7 | 397,1 | 16,9 |
Working assets | 461,3 | 474,6 | 539 | 13,6 |
Operating profit (EBIT) | 43,7 | -10,1 | 59,8 | 690,6 |
Depreciation | 12,6 | 10,8 | 20,9 | 94,1 |
% | % | % | p.p. | |
Profitability of capital | 11,4 | -2,9 | 14,4 | 17,3 |
Equity capital to total assets | 70,5 | 64,3 | 69,4 | 5,1 |
Gross profit margin | 46,4 | -11,7 | 51,1 | 62,8 |
EBITDA Margin | 59,8 | 0,8 | 65,6 | 64,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 565 | 852 | 520 | -332 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane